Cargando…
Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats
Active vitamin D form 1α,25-dihydroxtvitamin D(3) (1,25(OH)(2)D(3)) plays pivotal roles in calcium homeostasis and osteogenesis via its transcription regulation effect via binding to vitamin D receptor (VDR). Mutated VDR often causes hereditary vitamin D-dependent rickets (VDDR) type II, and patient...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307643/ https://www.ncbi.nlm.nih.gov/pubmed/35869242 http://dx.doi.org/10.1038/s41598-022-16819-7 |
_version_ | 1784752808214396928 |
---|---|
author | Nishikawa, Miyu Murose, Naruhiro Mano, Hiroki Yasuda, Kaori Isogai, Yasuhiro Kittaka, Atsushi Takano, Masashi Ikushiro, Shinichi Sakaki, Toshiyuki |
author_facet | Nishikawa, Miyu Murose, Naruhiro Mano, Hiroki Yasuda, Kaori Isogai, Yasuhiro Kittaka, Atsushi Takano, Masashi Ikushiro, Shinichi Sakaki, Toshiyuki |
author_sort | Nishikawa, Miyu |
collection | PubMed |
description | Active vitamin D form 1α,25-dihydroxtvitamin D(3) (1,25(OH)(2)D(3)) plays pivotal roles in calcium homeostasis and osteogenesis via its transcription regulation effect via binding to vitamin D receptor (VDR). Mutated VDR often causes hereditary vitamin D-dependent rickets (VDDR) type II, and patients with VDDR-II are hardly responsive to physiological doses of 1,25(OH)D(3). Current therapeutic approaches, including high doses of oral calcium and supraphysiologic doses of 1,25(OH)(2)D(3,) have limited success and fail to improve the quality of life of affected patients. Thus, various vitamin D analogues have been developed as therapeutic options. In our previous study, we generated genetically modified rats with mutated Vdr(R270L), an ortholog of human VDR(R274L) isolated from the patients with VDDR-II. The significant reduced affinity toward 1,25(OH)(2)D(3) of rat Vdr(R270L) enabled us to evaluate biological activities of exogenous VDR ligand without 1α-hydroxy group such as 25(OH)D(3). In this study, 2α-[2-(tetrazol-2-yl)ethyl]-1α,25(OH)(2)D(3) (AH-1) exerted much higher affinity for Vdr(R270L) in in vitro ligand binding assay than both 25(OH)D(3) and 1,25(OH)(2)D(3). A robust osteogenic activity of AH-1 was observed in Vdr(R270L) rats. Only a 40-fold lower dose of AH-1 than that of 25(OH)D(3) was effective in ameliorating rickets symptoms in Vdr(R270L) rats. Therefore, AH-1 may be promising for the therapy of VDDR-II with VDR(R274L). |
format | Online Article Text |
id | pubmed-9307643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93076432022-07-24 Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats Nishikawa, Miyu Murose, Naruhiro Mano, Hiroki Yasuda, Kaori Isogai, Yasuhiro Kittaka, Atsushi Takano, Masashi Ikushiro, Shinichi Sakaki, Toshiyuki Sci Rep Article Active vitamin D form 1α,25-dihydroxtvitamin D(3) (1,25(OH)(2)D(3)) plays pivotal roles in calcium homeostasis and osteogenesis via its transcription regulation effect via binding to vitamin D receptor (VDR). Mutated VDR often causes hereditary vitamin D-dependent rickets (VDDR) type II, and patients with VDDR-II are hardly responsive to physiological doses of 1,25(OH)D(3). Current therapeutic approaches, including high doses of oral calcium and supraphysiologic doses of 1,25(OH)(2)D(3,) have limited success and fail to improve the quality of life of affected patients. Thus, various vitamin D analogues have been developed as therapeutic options. In our previous study, we generated genetically modified rats with mutated Vdr(R270L), an ortholog of human VDR(R274L) isolated from the patients with VDDR-II. The significant reduced affinity toward 1,25(OH)(2)D(3) of rat Vdr(R270L) enabled us to evaluate biological activities of exogenous VDR ligand without 1α-hydroxy group such as 25(OH)D(3). In this study, 2α-[2-(tetrazol-2-yl)ethyl]-1α,25(OH)(2)D(3) (AH-1) exerted much higher affinity for Vdr(R270L) in in vitro ligand binding assay than both 25(OH)D(3) and 1,25(OH)(2)D(3). A robust osteogenic activity of AH-1 was observed in Vdr(R270L) rats. Only a 40-fold lower dose of AH-1 than that of 25(OH)D(3) was effective in ameliorating rickets symptoms in Vdr(R270L) rats. Therefore, AH-1 may be promising for the therapy of VDDR-II with VDR(R274L). Nature Publishing Group UK 2022-07-22 /pmc/articles/PMC9307643/ /pubmed/35869242 http://dx.doi.org/10.1038/s41598-022-16819-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Nishikawa, Miyu Murose, Naruhiro Mano, Hiroki Yasuda, Kaori Isogai, Yasuhiro Kittaka, Atsushi Takano, Masashi Ikushiro, Shinichi Sakaki, Toshiyuki Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title | Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title_full | Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title_fullStr | Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title_full_unstemmed | Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title_short | Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats |
title_sort | robust osteogenic efficacy of 2α-heteroarylalkyl vitamin d analogue ah-1 in vdr (r270l) hereditary vitamin d-dependent rickets model rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307643/ https://www.ncbi.nlm.nih.gov/pubmed/35869242 http://dx.doi.org/10.1038/s41598-022-16819-7 |
work_keys_str_mv | AT nishikawamiyu robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT murosenaruhiro robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT manohiroki robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT yasudakaori robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT isogaiyasuhiro robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT kittakaatsushi robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT takanomasashi robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT ikushiroshinichi robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats AT sakakitoshiyuki robustosteogenicefficacyof2aheteroarylalkylvitamindanalogueah1invdrr270lhereditaryvitaminddependentricketsmodelrats |